New cancer drug duo enters human testing for Tough-to-Treat tumors
NCT ID NCT07466160
Summary
This study is testing a new combination of two experimental drugs, 7MW3711 and JS207, for people with advanced solid tumors that have progressed after standard treatments. The main goals are to find the safest and most effective doses and to see if the combination can help control the cancer. The trial will also test adding standard chemotherapy to the drug combination for some participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200043, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.